Jiangchuan earned his medical degree from Tongji University in China in 2009. He attended the postgraduate program in internal medicine at the same institution, with a research interest on molecular cardiac physiology. After completing his PhD training, he joined Ellinor lab at Massachusetts General Hospital in 2013. His main projects focused on identifying atrial fibrillation-related functional SNPs and the underlying mechanisms by the use of stem cells and zebrafish models. Since 2017, Jiangchuan has transitioned to work on assay development and target identification using a variety of genome editing tools in combination with stem cell derived cardiomyocyte models. He also maintains the stem cell platform in CVDI providing supports of differentiated cardiomyocytes and CRISPR line generation for projects within the team.